Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR1Q1 Inhibitors

OR1Q1 inhibitors are a class of chemical compounds specifically designed to target the OR1Q1 receptor, which belongs to the olfactory receptor family within the G-protein-coupled receptor (GPCR) superfamily. Olfactory receptors, including OR1Q1, are primarily known for their role in detecting odor molecules, enabling the sense of smell. However, like many other olfactory receptors, OR1Q1 is also expressed in non-olfactory tissues, where it may participate in various physiological processes beyond olfaction. OR1Q1 inhibitors function by binding to this receptor and blocking or modulating its interaction with natural ligands. This inhibition can lead to alterations in the receptor's signaling pathways, potentially impacting the biological processes regulated by OR1Q1. The study of OR1Q1 inhibitors is important for understanding the broader biological functions of this receptor, especially in contexts where its role is not fully understood. The chemical properties of OR1Q1 inhibitors can be diverse, reflecting different structural classes and mechanisms of action. Some inhibitors are designed as competitive antagonists that bind directly to the receptor's active site, thereby preventing natural ligands from activating the receptor and initiating signal transduction. Other inhibitors may function allosterically, binding to distinct sites on the receptor and inducing conformational changes that diminish its activity or alter its signaling behavior. The development and optimization of OR1Q1 inhibitors typically involve advanced structural biology techniques, such as X-ray crystallography, cryo-electron microscopy, and computational modeling, to identify critical binding sites on the receptor and enhance the specificity and potency of the inhibitors. Researchers focus on ensuring that these inhibitors are highly selective for OR1Q1, minimizing off-target effects on other GPCRs or proteins. Through the study of OR1Q1 inhibitors, scientists aim to elucidate the precise functions of this receptor in various biological systems and to explore how modulation of its activity can influence specific cellular pathways.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

L-type calcium channel blocker that can inhibit calcium-mediated signaling in neurons, including those pathways associated with OR1Q1.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Inactivates Gi/o type G proteins, altering GPCR signaling and can disrupt OR1Q1-mediated pathways.

ODQ

41443-28-1sc-200325
sc-200325A
10 mg
50 mg
$78.00
$222.00
13
(1)

Inhibits soluble guanylyl cyclase, potentially affecting cyclic GMP levels and can disrupt the signaling processes involving OR1Q1.

Gö 6976

136194-77-9sc-221684
500 µg
$227.00
8
(1)

Protein kinase C inhibitor that can affect downstream signaling of GPCRs, including OR1Q1.

Clozapine

5786-21-0sc-200402
sc-200402A
sc-200402B
sc-200402C
50 mg
500 mg
5 g
10 g
$69.00
$364.00
$2500.00
$4100.00
11
(1)

Dopamine antagonist that can modulate dopaminergic signaling and can indirectly affect OR1Q1.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C, potentially affecting the phosphorylation state of proteins in pathways involving OR1Q1.

Niflumic acid

4394-00-7sc-204820
5 g
$32.00
3
(1)

Inhibits certain chloride channels, which can modulate cellular excitability and signaling pathways related to OR1Q1.